Over the past 20 years, there have been dramatic advances in treatment options for people diagnosed with non-small cell lung ...

The University of Kentucky Markey Cancer Center's Graham Warren, M.D., Ph.D., and international collaborators have led a ...

University of Colorado Cancer Center member D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, ...

A study of nearly half a million women found the risk of a secondary cancer after breast cancer was only 2 percent higher ...

Crizotinib, an approved treatment for advanced ALK-positive (ALK+) non-small cell lung cancer (NSCLC), did not improve ...

Dr Srivatsa Lokeshwaran highlights how CBCT is transforming early lung cancer detection and diagnosis in India ...

The therapy is said to have shown favourable tumour uptake and quick elimination from the bloodstream and critical organs.

The vaccine contains four non-harmful viruses which activate immune response, while focusing on tumor destruction. The ...

The American Society for Radiation Oncology (ASTRO) announced today the press program for its 2025 Annual Meeting this month in San Francisco. Researchers will discuss their findings in news briefings ...

Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for ...

A multi-center, randomized phase III trial has found that a three-week hypofractionated radiotherapy (HypoRT) schedule with ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.